Mga Batayang Estadistika
| CIK | 1374536 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| August 14, 2015 |
MMMS / 10-Q - Quarterly Report - QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2015 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 000-54346 MEDYTOX SOLUTIONS, |
|
| July 17, 2015 |
Rennova Health REGISTRATION STATEMENT As filed with the Securities and Exchange Commission on July 17, 2015 Registration No. |
|
| July 16, 2015 |
MMMS / / Lagan Seamus - SCHEDULE 13D AMENDMENT Activist Investment SC 13D/A 1 medytox13da4-lagan.htm SCHEDULE 13D AMENDMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 4)* Medytox Solutions, Inc. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 58509R104 (CUSIP Number) Seamus Lagan 400 South Australian Avenue, 8th Floor West Palm Beach, |
|
| June 2, 2015 |
MMMS / / Lagan Seamus - AMENDMENT NO. 3 Activist Investment SC 13D/A 1 medytox13da3-lagan.htm AMENDMENT NO. 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3)* Medytox Solutions, Inc. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 58509R104 (CUSIP Number) Seamus Lagan 400 South Australian Avenue, 8th Floor West Palm Beach, FL 334 |
|
| June 1, 2015 |
MMMS / / Roca Francisco III - SCHEDULE 13D AMENDMENT Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2 )* Medytox Solutions, Inc. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 58509R104 (CUSIP Number) Francisco Roca, III 400 South Australian Avenue, 8th Floor West Palm Beach, FL 33401 (561) 855-1626 (Name, Address and Telep |
|
| June 1, 2015 |
MMMS / / Sramowicz Steven - SCHEDULE 13D AMENDMENT Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2 )* Medytox Solutions, Inc. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 58509R104 (CUSIP Number) Steven Sramowicz 400 South Australian Avenue, 8th Floor West Palm Beach, FL 33401 (561) 855-1626 (Name, Address and Telephon |
|
| April 24, 2015 |
MMMS / / Forhan William - AMENDMENT NO. 1 TO SC 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1 )* Medytox Solutions, Inc. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 58509R104 (CUSIP Number) William G. Forhan 400 South Australian Avenue, 8th Floor West Palm Beach, FL 33401 (561) 855-1626 (Name, Address and Telepho |
|
| March 23, 2015 |
MMMS / / Hollis Sharon Lynne - SCHEDULE 13D AMENDMENT Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* Medytox Solutions, Inc. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 58509R104 (CUSIP Number) Sharon Lynne Hollis 400 South Australian Avenue, 8th Floor West Palm Beach, FL 33401 (561) 855-1626 (Name, Address and Teleph |
|
| March 23, 2015 |
MMMS / / Lagan Seamus - AMENDMENT NO. 2 Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* Medytox Solutions, Inc. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 58509R104 (CUSIP Number) Seamus Lagan 400 South Australian Avenue, 8th Floor West Palm Beach, FL 33401 (561) 855-1626 (Name, Address and Telephone Num |
|
| February 25, 2015 |
MMMS / 425 - Merger Prospectus - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 19, 2015 Medytox Solutions, Inc. (Exact Name of Registrant as Specified in Its Charter) Nevada (State or Other Jurisdiction of Incorporation) 000-54346 90-0902741 (Commission |
|
| February 25, 2015 |
8-K 1 medytox8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 19, 2015 Medytox Solutions, Inc. (Exact Name of Registrant as Specified in Its Charter) Nevada (State or Other Jurisdiction of Incorporation) 000 |
|
| February 18, 2015 |
EX-99.1 3 medytoxex9901.htm PRESS RELEASE EX-99.1 News Contact: Meieli Sawyer From Medytox Solutions, Inc. The Weinbach Group, Inc. For Immediate Release (305) 668-0070 [email protected] INTEGRATED HEALTHCARE COMPANY, MEDYTOX SOLUTIONS, INC., NAMES NEW COO Samuel R. Mitchell, Jr., MBA, MHA, To Oversee Day-To-Day Operations West Palm Beach, FL – February 18, 2015 – Medytox Solutions, Inc., |
|
| February 18, 2015 |
8-K 1 medytox8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 4, 2015 Medytox Solutions, Inc. (Exact Name of Registrant as Specified in Its Charter) Nevada (State or Other Jurisdiction of Incorporation) 000- |
|
| February 18, 2015 |
EX-10.1 2 medytox8k-ex1001.htm EMPLOYMENT AGREEMENT Exhibit 10.1 EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT ("Agreement"), effective as of February 4, 2015, is made and entered into by and between Medytox Solutions, Inc., a Nevada corporation with its principal place of business at 400 South Australian Avenue, Suite 800, West Palm Beach, Florida, 33401, together with its successors and assigns |
|
| January 22, 2015 |
EX-99.1 2 medytox8k-ex9901.htm PRESS RELEASE Exhibit 99.1 CollabRx and Medytox Solutions Sign Non-Binding Letter of Intent for Possible Business Combination CollabRx Receives Funding from Medytox for Continued Operation SAN FRANCISCO, CA and WEST PALM BEACH, FL - Jan. 22, 2015 - CollabRx, Inc. (NASDAQ:CLRX) and Medytox Solutions, Inc. (OTCQB: MMMS) (“Medytox”) have entered into a non-binding lette |
|
| January 22, 2015 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): January 16, 2015 Medytox Solutions, Inc. (Exact Name of Registrant as Specified in Its Charter) Nevada (State or Other Jurisdiction of Incorporation) 000-54346 90-0902741 (Commission |
|
| January 22, 2015 |
Exhibit 99.1 CollabRx and Medytox Solutions Sign Non-Binding Letter of Intent for Possible Business Combination CollabRx Receives Funding from Medytox for Continued Operation SAN FRANCISCO, CA and WEST PALM BEACH, FL - Jan. 22, 2015 - CollabRx, Inc. (NASDAQ:CLRX) and Medytox Solutions, Inc. (OTCQB: MMMS) (“Medytox”) have entered into a non-binding letter of intent to negotiate a potential business |
|
| January 22, 2015 |
MMMS / 425 - Merger Prospectus - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): January 16, 2015 Medytox Solutions, Inc. (Exact Name of Registrant as Specified in Its Charter) Nevada (State or Other Jurisdiction of Incorporation) 000-54346 90-0902741 (Commission |
|
| November 17, 2014 |
NT 10-Q 1 medytoxext-093014.htm EXTENSION UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC File Number: 333-138251 CUSIP Number: (Check one): [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period Ended: September 30, 2014 [ ] Transition Report on Form 10-K [ ] Transition Repo |
|
| October 7, 2014 |
Exhibit 16.1 2451 N. McMullen Booth Road Suite 308 Clearwater, FL 33759 Toll fee: 855.334.0934 Fax: 800.581.1908 October 2, 2014 Office of the Chief Accountant Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 Dear Sir/Madam: We have read the statements included in the Form 8-K dated October 2, 2014, of Medytox Solutions, Inc., to be filed with the Securities and Exchange |
|
| October 7, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 2, 2014 Medytox Solutions, Inc. (Exact name of registrant as specified in its charter) Nevada 000-54346 54-2156042 (State or Other jurisdiction of Incorporation) (Commission F |
|
| September 12, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 11, 2014 Medytox Solutions, Inc. (Exact Name of Registrant as Specified in Its Charter) Nevada (State or Other Jurisdiction of Incorporation) 000-54346 54-2156042 (Commissio |
|
| September 12, 2014 |
Exhibit 10.1 AGREEMENT FOR THE RETIREMENT AS CEO AND RELEASE OF ANY AND ALL CLAIMS THIS AGREEMENT FOR THE RETIREMENT AS CEO AND RELEASE OF ANY AND ALL CLAIMS (“Agreement”) sets forth the voluntary agreement reached between William G. Forhan (“Mr. Forhan”) and Medytox Solutions, Inc. (the “Company”). WHEREAS, Mr. Forhan has been employed with the Company in the capacity of Chief Executive Officer p |
|
| September 12, 2014 |
Exhibit 10.2 AMENDMENT TO CONSULTING AGREEMENT This Amendment to Consulting Agreement, dated as of September 11, 2014 ("Amendment"), between Alcimede LLC, a Delaware limited liability company (the "Company"), and Medytox Solutions, Inc., a Nevada corporation (the "Client"). WHEREAS, the Company and the Client are parties to that certain Consulting Agreement, dated as of October 1, 2012 (the "Agree |
|
| August 28, 2014 |
EX-10.1 3 medytox8k-ex1001.htm STOCK PURCHASE AGREEMENT EXHIBIT 10.1 STOCK PURCHASE AGREEMENT BY AND AMONG EPINEX DIAGNOSTICS LABORATORIES, INC., EPINEX DIAGNOSTICS, INC., MEDYTOX DIAGNOSTICS, INC. and MEDYTOX SOLUTIONS, INC. August 26, 2014 TABLE OF CONTENTS ARTICLE I PURCHASE AND SALE 1 Section 1.1 Purchase and Sale 1 Section 1.2 Closing Date 2 ARTICLE II REPRESENTATIONS AND WARRANTIES OF SELLER |
|
| August 28, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 21, 2014 Medytox Solutions, Inc. (Exact Name of Registrant as Specified in Its Charter) Nevada (State or Other Jurisdiction of Incorporation) 000-54346 54-2156042 (Commission F |
|
| August 28, 2014 |
Certificate of Designation For Nevada Profit Corporations (Pursuant to NRS 78.1955) EXHIBIT 3.1 Certificate of Designation For Nevada Profit Corporations (Pursuant to NRS 78.1955) 1. Name of corporation: MEDYTOX SOLUTIONS, INC. 2. By resolution of the board of directors pursuant to a provision in the articles of incorporation this certificate establishes the following regarding the voting powers, designations, preferences, limitations, restrictions and relative rights of the foll |
|
| August 19, 2014 |
Medytox Solutions, Inc. Announces Results for the Three and Six Months Ended June 30, 2014 Exhibit 99.1 Medytox Solutions, Inc. Announces Results for the Three and Six Months Ended June 30, 2014 Medytox Solutions, Inc. (OTCQB: MMMS) (August 18, 2014) announced today its financial results for the three-month period ended June 30, 2014 (the “2014 Quarter”), and the six-month period ended June 30, 2014 (the "2014 Period"). For the 2014 Quarter, the Company reported revenues of approximatel |
|
| August 19, 2014 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 18, 2014 Medytox Solutions, Inc. (Exact Name of Registrant as Specified in Its Charter) Nevada (State or Other Jurisdiction of Incorporation) 000-54346 54-2156042 (Commission F |
|
| June 5, 2014 |
EX-99.1 2 medytoxex9901.htm PRESS RELEASE Exhibit 99.1 MEDYTOX SOLUTIONS, INC. ANNOUNCES ACQUISITION OF DEVELOPER OF ELECTRONIC HEALTH RECORDS MANAGEMENT AND STORAGE SOFTWARE Medytox Solutions, Inc. (OTCQB: MMMS) (June 5, 2014) announced today that it has acquired substantially all of the assets of Globalone Information Technologies, LLC, a company that specializes in Electronic Health Records (EH |
|
| June 5, 2014 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 5, 2014 Medytox Solutions, Inc. (Exact Name of Registrant as Specified in Its Charter) Nevada (State or Other Jurisdiction of Incorporation) 000-54346 54-2156042 (Commission File |
|
| May 16, 2014 |
Medytox Solutions, Inc. Announces Results for the Three Months Ended March 31, 2014 EX-99.1 2 medytoxex9901.htm PRESS RELEASE Exhibit 99.1 Medytox Solutions, Inc. Announces Results for the Three Months Ended March 31, 2014 Medytox Solutions, Inc. (OTCQB: MMMS) (May 16, 2014) announced today its financial results for the three-month period ended March 31, 2014. For the three months ended March 31, 2014, the Company reported revenues of approximately $21.1 million, which represents |
|
| May 16, 2014 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 16, 2014 Medytox Solutions, Inc. (Exact Name of Registrant as Specified in Its Charter) Nevada (State or Other Jurisdiction of Incorporation) 000-54346 54-2156042 (Commission File |
|
| April 10, 2014 |
MMMS / / Roca Francisco III - SCHEDULE 13D AMENDMENT Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1 )* Medytox Solutions, Inc. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 58509R104 (CUSIP Number) Francisco Roca, III 400 South Australian Avenue, 8th Floor West Palm Beach, FL 33401 (561) 855-1626 (Name, Address and Telep |
|
| April 8, 2014 |
MMMS / / Sramowicz Steven - SCHEDULE 13D AMENDMENT Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1 )* Medytox Solutions, Inc. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 58509R104 (CUSIP Number) Steven Sramowicz 400 South Australian Avenue, 8th Floor West Palm Beach, FL 33401 (561) 855-1626 (Name, Address and Telephon |
|
| April 7, 2014 |
Medytox Solutions, Inc. Announces Results for the Year Ended December 31, 2013 EX-99.1 2 medytox8k-ex9901.htm PRESS RELEASE Exhibit 99.1 Medytox Solutions, Inc. Announces Results for the Year Ended December 31, 2013 Medytox Solutions, Inc. (OTC Bulletin Board: MMMS) (April 7, 2014) announced today its financial results for the year ended December 31, 2013 (the “2013 Year”). The Company reported revenues of approximately $52.5 million, which represented an increase of approxi |
|
| April 7, 2014 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 7, 2014 Medytox Solutions, Inc. (Exact Name of Registrant as Specified in Its Charter) Nevada (State or Other Jurisdiction of Incorporation) 000-54346 54-2156042 (Commission Fil |
|
| April 7, 2014 |
MMMS / / Mendolia Thomas Francis DO - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* Medytox Solutions, Inc. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 58509R104 (CUSIP Number) Thomas Francis Mendolia 400 South Australian Avenue, 8th Floor West Palm Beach, FL 33401 (561) 855-1626 (Name, Address and Te |
|
| March 19, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 13, 2014 Medytox Solutions, Inc. (Exact Name of Registrant as Specified in Its Charter) Nevada (State or Other Jurisdiction of Incorporation) 000-54346 54-2156042 (Commission Fi |
|
| March 19, 2014 |
EX-10.1 2 medytox8k-ex1001.htm INCENTIVE COMPENSATION PLAN RESTRICTED STOCK AGREEMENT Exhibit 10.1 MEDYTOX SOLUTIONS, INC. 2013 INCENTIVE COMPENSATION PLAN FORM OF RESTRICTED STOCK AGREEMENT THIS RESTRICTED STOCK AGREEMENT (this “Agreement”), is made and effective as of this day of , (the “Grant Date”), by and between Medytox Solutions, Inc., a Nevada corporation (“Medytox”), and (the “Participant |
|
| February 13, 2014 |
MMMS / / Forhan William - SC 13D Activist Investment Schedule 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Medytox Solutions, Inc. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 58509R104 (CUSIP Number) William G. Forhan 400 South Australian Avenue, 8th Floor West Palm Beach, FL 33401 (561) 855-1626 (Name, Address |
|
| December 23, 2013 |
S-8 1 medytoxs8.htm FORM S-8 As filed with the Securities and Exchange Commission on December 23, 2013 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MEDYTOX SOLUTIONS, INC. (Exact name of registrant as specified in its charter) Nevada 54-2156042 (State or other jurisdiction of incorpora |
|
| December 23, 2013 |
Exhibit 4.1 MEDYTOX SOLUTIONS, INC. 2013 INCENTIVE COMPENSATION PLAN 1. ESTABLISHMENT, EFFECTIVE DATE AND TERM Medytox Solutions, Inc., a Nevada corporation, hereby establishes the Medytox Solutions, Inc. 2013 Incentive Compensation Plan. The Effective Date of the Plan shall be the later of: (i) the date the Plan was approved by the Board, and (ii) the date the Plan was approved by stockholders of |
|
| November 26, 2013 |
- DEFINITIVE INFORMATION STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 (Amendment No. ) Check the appropriate box: o Preliminary Information Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) þ Definitive Information Statement Medytox Solutions, |
|
| November 14, 2013 |
Medytox Solutions, Inc. Announces Results for the Three and Nine Months Ended September 30, 2013 EX-99.1 2 medytox8k-ex9901.htm PRESS RELEASE Exhibit 99.1 Press Release Medytox Solutions, Inc. Announces Results for the Three and Nine Months Ended September 30, 2013 West Palm Beach, Florida November 8, 2013, Medytox Solutions, Inc. (OTCBB: MMMS) announces Results for the Three and Nine Months Ended September 30, 2013 Medytox Solutions, Inc. (OTC Bulletin Board: MMMS) announced financial result |
|
| November 14, 2013 |
Financial Statements and Exhibits, Other Events - CURRENT REPORT ON FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 8, 2013 Medytox Solutions, Inc. (Exact Name of Registrant as Specified in Its Charter) Nevada (State or Other Jurisdiction of Incorporation) 000-54346 54-2156042 (Commission |
|
| November 5, 2013 |
MMMS / / Lagan Seamus - AMENDMENT NO. 1 Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* Medytox Solutions, Inc. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 58509R104 (CUSIP Number) Seamus Lagan 400 South Australian Avenue, 8th Floor West Palm Beach, FL 33401 (561) 855-1626 (Name, Address and Telephone Num |
|
| October 29, 2013 |
MMMS / / Lagan Seamus - SCHEDULE 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Medytox Solutions, Inc. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 58509R104 (CUSIP Number) Seamus Lagan 400 South Australian Avenue, 8th Floor West Palm Beach, FL 33401 (561) 855-1626 (Name, Address and Telephone Numb |
|
| September 13, 2013 |
Other Events - CURRENT REPORT ON FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 16, 2013 Medytox Solutions, Inc. (Exact Name of Registrant as Specified in Its Charter) Nevada (State or Other Jurisdiction of Incorporation) 000-54346 54-2156042 (Commission F |
|
| July 24, 2013 |
THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. |
|
| July 24, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 15, 2013 Medytox Solutions, Inc. (Exact Name of Registrant as Specified in Its Charter) Nevada (State or Other Jurisdiction of Incorporation) 000-54346 54-2156042 (Commission Fil |
|
| July 24, 2013 |
GUARANTY AGREEMENT THIS GUARANTY AGREEMENT is dated as of July 15, 2013 (as amended, restated, supplemented or modified from time to time, the “Guaranty”), and is made by INTERNATIONAL TECHNOLOGIES, LLC, a New Jersey limited liability company, as guarantor (the “Guarantor”), in favor of TCA GLOBAL CREDIT MASTER FUND, LP, as guarantee (the “Lender”). |
|
| July 24, 2013 |
AMENDMENT NO. 4 TO SENIOR SECURED REVOLVING CREDIT FACILITY AGREEMENTIN THE AMOUNT OF US$15,000,000 BY AND AMONG MEDYTOX SOLUTIONS, INC.,as Borrower, MEDYTOX MEDICAL MARKETING & SALES, INC.,BIOHEALTH MEDICAL LABORATORY, INC.,ADVANTAGE REFERENCE LABS, INC., MEDYTOX DIAGNOSTICS, INC.,PB LABORATORIES, LLC,ALETHEA LABORATORIES, INC., andINTERNATIONAL TECHNOLOGIES, LLC,as Joint and Several Guarantors, |
|
| July 24, 2013 |
GUARANTY AGREEMENT THIS GUARANTY AGREEMENT is dated as of July 15, 2013 (as amended, restated, supplemented or modified from time to time, the “Guaranty”), and is made by ALETHEA LABORATORIES, INC. |
|
| July 24, 2013 |
SECURITY AGREEMENT This SECURITY AGREEMENT, effective as of July 15, 2013 (as amended, restated, supplemented or modified from time to time, the “Security Agreement”), is executed by and between INTERNATIONAL TECHNOLOGIES, LLC, a New Jersey limited liability company, whose address is 71 Franklin Turnpike, Suite 1-3, Waldwick, New Jersey 07463. |
|
| July 24, 2013 |
SECURITY AGREEMENT This SECURITY AGREEMENT, effective as of July 15, 2013 (as amended, restated, supplemented or modified from time to time, the “Security Agreement”), is executed by and between ALETHEA LABORATORIES, INC. |
|
| July 11, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 2, 2013 MEDYTOX SOLUTIONS, INC. (Exact name of registrant as specified in its charter) Nevada 000-54346 54-2156042 (State or other jurisdiction of incorporation) (Commission File |
|
| July 10, 2013 |
MMMS / / SIMMONS JACE - SCHEDULE 13D Activist Investment SCHEDULE 13D CUSIP No. 58509R104 Page 1 of 5 Pages UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Medytox Solutions, Inc. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 58509R104 (CUSIP Number) Jace Simmons 400 South Australian Avenue, 8th Floor West Palm Beach, FL 334 |
|
| June 17, 2013 |
MMMS / / Sramowicz Steven - SC 13D Activist Investment SC 13D SCHEDULE 13D CUSIP No. 58509R104 Page 1 of 5 Pages UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Medytox Solutions, Inc. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 58509R104 (CUSIP Number) Steven Sramowicz 400 South Australian Avenue, 8th Floor West Palm Be |
|
| June 12, 2013 |
MMMS / / Roca Francisco III - SCHEDULE 13D Activist Investment SC 13D 1 d553333dsc13d.htm SCHEDULE 13D SCHEDULE 13D CUSIP No. 58509R104 Page 1 of 5 Pages UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Medytox Solutions, Inc. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 58509R104 (CUSIP Number) Francisco Roca III 400 South Austra |
|
| June 12, 2013 |
MMMS / / Mendolia Thomas Francis DO - SC 13D Activist Investment SC 13D SCHEDULE 13D CUSIP No. 58509R104 Page 1 of 5 Pages UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Medytox Solutions, Inc. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 58509R104 (CUSIP Number) Thomas Francis Mendolia 400 South Australian Avenue, 8th Floor West |
|
| June 12, 2013 |
MMMS / / Hollis Sharon Lynne - SC 13D Activist Investment SC 13D SCHEDULE 13D CUSIP No. 58509R104 Page 1 of 5 Pages UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Medytox Solutions, Inc. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 58509R104 (CUSIP Number) Sharon Lynne Hollis 400 South Australian Avenue, 8th Floor West Palm |
|
| April 26, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 19, 2013 Medytox Solutions, Inc. (Exact Name of Registrant as Specified in Its Charter) Nevada (State or Other Jurisdiction of Incorporation) 000-54346 54-2156042 (Commission Fi |
|
| April 26, 2013 |
MEDYTOX SOLUTIONS INC. STAND-ALONE OPTION GRANT AGREEMENT DIRECTORS THIS STAND-ALONE OPTION GRANT AGREEMENT (this “Agreement”) effective as of the 19th day of April, 2013 (the “Option Date”) by and between Medytox Solutions, Inc., a Nevada corporation (the “Company”), and Christopher E. Diamantis (the “Optionee”). Capitalized terms used but not defined herein are defined in Appendix A attached her |
|
| April 26, 2013 |
MEDYTOX SOLUTIONS INC. STAND-ALONE OPTION GRANT AGREEMENT DIRECTORS THIS STAND-ALONE OPTION GRANT AGREEMENT (this "Agreement") effective as of the 19111 day of April, 2013 (the "Option Date") by and between Medytox Solutions Inc. a Nevada corporation (the "Company"), and Benjamin Frank (the "Optionee"). Capitalized terms used but not defined herein are defined in Appendix A attached hereto, which |
|
| April 1, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC File Number: 333-138251 CUSIP Number: (Check one): [X] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period Ended: December 31, 2012 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Fo |
|
| March 15, 2013 |
SECURITY AGREEMENT This SECURITY AGREEMENT, effective as of February 28, 2013 (as amended, restated, supplemented or modified from time to time, the “Security Agreement”), is executed by and between ADVANTAGE REFERENCE LABS, INC. |
|
| March 15, 2013 |
AMENDMENT NO. 3 TO SENIOR SECURED REVOLVING CREDIT FACILITY AGREEMENTIN THE AMOUNT OF US$15,000,000 BY AND AMONG MEDYTOX SOLUTIONS, INC.,as Borrower, MEDYTOX MEDICAL MARKETING & SALES, INC.,BIOHEALTH MEDICAL LABORATORY, INC.,ADVANTAGE REFERENCE LABS, INC., MEDYTOX DIAGNOSTICS, INC., andPB LABORATORIES, LLCas Joint and Several Guarantors, AND TCA GLOBAL CREDIT MASTER FUND, LP,as Lender February 28, |
|
| March 15, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): January 22, 2013 Medytox Solutions, Inc. (Exact Name of Registrant as Specified in Its Charter) Nevada (State or Other Jurisdiction of Incorporation) 000-54346 54-2156042 (Commission |
|
| March 15, 2013 |
Converted by EDGARwiz THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. |
|
| March 15, 2013 |
GUARANTY AGREEMENT THIS GUARANTY AGREEMENT is dated as of February 28, 2013 (as amended, restated, supplemented or modified from time to time, the “Guaranty”), and is made by ADVANTAGE REFERENCE LABS, INC. |
|
| March 15, 2013 |
SECURITY AGREEMENT This SECURITY AGREEMENT, effective as of January 22, 2013 (as amended, restated, supplemented or modified from time to time, the “Security Agreement”), is executed by and between BIOHEALTH MEDICAL LABORATORY, INC. |
|
| March 15, 2013 |
GUARANTY AGREEMENT THIS GUARANTY AGREEMENT is dated as of January 22, 2013 (as amended, restated, supplemented or modified from time to time, the “Guaranty”), and is made by BIOHEALTH MEDICAL LABORATORY, INC. |
|
| January 18, 2013 |
Converted by EDGARwiz Drake Klein Messineo CPAs, PA 2451 N. McMullen Booth Road, Suite 308 Clearwater Florida 33759-1362 727.444.0931 www.dkmcpas.com EXHIBIT 16.1 January 16, 2013 Securities and Exchange Commission Washington, DC 20549 Commissioners: We have read Item 4.01 of Medytox Solutions, Inc.'s Form 8-K dated January 10, 2012, and we agree with such statements insofar as they relate to our |
|
| January 18, 2013 |
Converted by EDGARwiz UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| January 15, 2013 |
MEDYTOX SOLUTIONS INC. STAND-ALONE OPTION GRANT AGREEMENT THIS STAND-ALONE OPTION GRANT AGREEMENT (this “Agreement”) dated as of the 31st day of December, 2012 (the “Grant Date”) by and between Medytox Solutions Inc., a Nevada corporation (the “Company”), and Robert Kuechenberg (the “Optionee”). Capitalized terms used but not defined herein are defined in Appendix A attached hereto, which is incor |
|
| January 15, 2013 |
M2950303.DOC;1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): December 31, 2012 Medytox Solutions, Inc. (Exact Name of Registrant as Specified in Its Charter) Nevada (State or Other Jurisdiction of Incorporation) 000-54346 54-2156 |
|
| January 15, 2013 |
MEDYTOX SOLUTIONS INC. STAND-ALONE OPTION GRANT AGREEMENT THIS STAND-ALONE OPTION GRANT AGREEMENT (this “Agreement”) dated as of the 31st day of December, 2012 (the “Grant Date”) by and between Medytox Solutions Inc., a Nevada corporation (the “Company”), and Joseph Fahoome (the “Optionee”). Capitalized terms used but not defined herein are defined in Appendix A attached hereto, which is incorpora |
|
| December 19, 2012 |
STOCK PURCHASE AGREEMENT BIOHEALTH MEDICAL LABORATORY, INC. THIS AGREEMENT is made and entered into as of December 7, 2012 (the "Effective Date"), by and between Luisa G. Suarez (the "Seller") and Medytox Diagnostics, Inc., a Florida corporation (the "Buyer" or "Medytox"). R E C I T A L S: A. Biohealth Medical Laboratory, Inc. (the "Company") (i) is a Florida corporation in good standing with the |
|
| December 19, 2012 |
SECURED PROMISSORY NOTE $165,125 December 7, 2012 FOR VALUE RECEIVED, the undersigned, MEDYTOX DIAGNOSTICS, INC. |
|
| December 19, 2012 |
M2996757.DOC;4 STOCK PURCHASE AGREEMENT BIOHEALTH MEDICAL LABORATORY, INC. THIS AGREEMENT is made and entered into as of December 7, 2012 (the "Effective Date"), by and between Balbino Suarez (the "Seller") and Medytox Diagnostics, Inc., a Florida corporation (the "Buyer" or "Medytox"). R E C I T A L S: A. Biohealth Medical Laboratory, Inc. (the "Company") (i) is a Florida corporation in good stan |
|
| December 19, 2012 |
GUARANTEE West Palm Beach, Florida 7th December, 2012 In order to induce BALBINO SUAREZ (hereinafter referred to as Holder) to make such advances and extensions of credit, directly or indirectly, to MEDYTOX DIAGNOSTICS, INC. |
|
| December 19, 2012 |
M2950303.DOC;1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): December 7, 2012 Medytox Solutions, Inc. (Exact Name of Registrant as Specified in Its Charter) Nevada (State or Other Jurisdiction of Incorporation) 000-54346 54-21560 |
|
| December 17, 2012 |
AMENDMENT NO. 2 TO SENIOR SECURED REVOLVING CREDIT FACILITY AGREEMENTIN THE AMOUNT OF US$15,000,000 BY AND AMONG MEDYTOX SOLUTIONS, INC.,as Borrower, MEDYTOX MEDICAL MARKETING & SALES, INC.,MEDYTOX DIAGNOSTICS, INC., andPB LABORATORIES, LLCas Joint and Several Guarantors, AND TCA GLOBAL CREDIT MASTER FUND, LP,as Lender October 31, 2012 {25398566;2}0 AMENDMENT NO. 2 TO SENIOR SECURED REVOLVING CRED |
|
| December 17, 2012 |
THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. |
|
| December 17, 2012 |
M2950303.DOC;1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): December 4, 2012 Medytox Solutions, Inc. (Exact Name of Registrant as Specified in Its Charter) Nevada (State or Other Jurisdiction of Incorporation) 000-54346 54-21560 |
|
| November 14, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC File Number: 333-138251 CUSIP Number: (Check one): [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period Ended: September 30, 2012 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on F |
|
| August 15, 2012 |
THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. |
|
| August 15, 2012 |
Converted by EDGARwiz AMENDMENT NO. 1 TO SENIOR SECURED REVOLVING CREDIT FACILITY AGREEMENT IN THE AMOUNT OF US$4,000,000 BY AND AMONG MEDYTOX SOLUTIONS, INC., as Borrower, MEDYTOX MEDICAL MARKETING & SALES, INC., MEDYTOX DIAGNOSTICS, INC, and PB LABORATORIES, LLC as Joint and Several Guarantors, AND TCA GLOBAL CREDIT MASTER FUND, LP, as Lender July 31, 2012 {24839909;1} AMENDMENT NO. 1 TO SENIOR |
|
| August 15, 2012 |
EXHIBIT "A" TO CERTIFICATE OF DESIGNATION MEDYTOX SOLUTIONS, INC. EXHIBIT "A" TO CERTIFICATE OF DESIGNATION MEDYTOX SOLUTIONS, INC. 2. Ranking. The Series B Preferred Stock shall rank: (i) senior to the Corporation's common stock, par value $.0001 per share ("Common Stock"); (ii) senior to any class or series of capital stock of the Corporation hereafter created (unless such class or series of capital stock specifically, by its terms, ranks senior to or pari pas |
|
| August 15, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 6, 2012 Medytox Solutions, Inc. (Exact Name of Registrant as Specified in Its Charter) Nevada (State or Other Jurisdiction of Incorporation) 000-54346 54-2156042 (Commission File |
|
| August 15, 2012 |
Converted by EDGARwiz AMENDMENT TO CONVERTIBLE PROMISSORY NOTE Amendment to Promissory Note, dated as of July 27, 2012 (this "Amendment"), between Medytox Solutions, Inc. |
|
| August 15, 2012 |
Converted by EDGARwiz AMENDMENT TO PROMISSORY NOTE Amendment to Promissory Note, dated as of July 27, 2012 (this "Amendment"), between Medytox Solutions, Inc. |
|
| August 15, 2012 |
Converted by EDGARwiz AMENDMENT TO SECURITY AGREEMENT Amendment to Security Agreement, dated as of July 27, 2012 (this "Amendment"), among Medytox Solutions, Inc. |
|
| May 21, 2012 |
SECURITY AGREEMENT This SECURITY AGREEMENT, dated effective as of April 30, 2012 (the “Security Agreement”), is executed by and between MEDYTOX DIAGNOSTICS, INC. |
|
| May 21, 2012 |
GUARANTY AGREEMENT THIS GUARANTY AGREEMENT is dated as of April 30, 2012 (together with any amendments or modifications hereto in effect from time to time, the “Guaranty”), and is made by PB LABORATORIES, LLC, a Florida limited liability company(the “Guarantor”), in favor of TCA GLOBAL CREDIT MASTER FUND, LP (the “Lender”). |
|
| May 21, 2012 |
SECURITY AGREEMENT This SECURITY AGREEMENT, dated effective as of April 30, 2012 (the “Security Agreement”), is executed by and between PB LABORATORIES, LLC, a Florida limited liability company(the “Grantor”), and TCA GLOBAL CREDIT MASTER FUND, LP (the “Secured Party”). |
|
| May 21, 2012 |
GUARANTY AGREEMENT THIS GUARANTY AGREEMENT is dated as of April 30, 2012 (together with any amendments or modifications hereto in effect from time to time, the “Guaranty”), and is made by MEDYTOX MEDICAL MARKETING & SALES, INC. |
|
| May 21, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 14, 2012 Medytox Solutions, Inc. (Exact Name of Registrant as Specified in Its Charter) Nevada (State or Other Jurisdiction of Incorporation) 000-54346 54-2156042 (Commission Fi |
|
| May 21, 2012 |
SENIOR SECURED REVOLVING CREDIT FACILITY AGREEMENT IN THE AMOUNT OF US$4,000,000 BY AND AMONG MEDYTOX SOLUTIONS, INC. |
|
| May 21, 2012 |
GUARANTY AGREEMENT THIS GUARANTY AGREEMENT is dated as of April 30, 2012 (together with any amendments or modifications hereto in effect from time to time, the “Guaranty”), and is made by MEDYTOX DIAGNOSTICS, INC. |
|
| May 21, 2012 |
THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. |
|
| May 21, 2012 |
SECURITY AGREEMENT This SECURITY AGREEMENT, dated effective as of April 30, 2012 (the “Security Agreement”), is executed by and between MEDYTOX SOLUTIONS, INC. |
|
| May 21, 2012 |
SECURITY AGREEMENT This SECURITY AGREEMENT, dated effective as of April 30, 2012 (the “Security Agreement”), is executed by and between MEDYTOX MEDICAL MARKETING & SALES, INC. |
|
| May 18, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 14, 2012 Medytox Solutions, Inc. (Exact Name of Registrant as Specified in Its Charter) Nevada (State or Other Jurisdiction of Incorporation) 000-54346 54-2156042 (Commission File |
|
| May 15, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC File Number: 333-138251 CUSIP Number: (Check one): [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period Ended: March 31, 2012 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form |
|
| March 30, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC File Number: 333-138251 CUSIP Number: (Check one): [X] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period Ended: December 31, 2011 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Fo |
|
| February 28, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 27, 2012 Medytox Solutions, Inc. (Exact Name of Registrant as Specified in Its Charter) Nevada (State or Other Jurisdiction of Incorporation) 000-54346 54-2156042 (Commission |
|
| February 28, 2012 |
EMPLOYMENT AGREEMENT THIS AGREEMENT (the "Agreement") effective the 1st day of March 1 2012, entered into by and between Jace Simmons ("Employee") and Medytox Solutions Inc. |
|
| February 17, 2012 |
MEMBERSHIP INTEREST PURCHASE AGREEMENT COLLECTAWAY, LLC THIS AGREEMENT is made and entered into as of February 16, 2012 (the "Effective Date"), by and between Marylu Villasenor-Hill (the "Seller") and Medytox Diagnostics, Inc. |
|
| February 17, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 16, 2012 Medytox Solutions, Inc. (Exact Name of Registrant as Specified in Its Charter) Nevada (State or Other Jurisdiction of Incorporation) 000-54346 54-2156042 (Commission |
|
| February 17, 2012 |
SECURED PROMISSORY NOTE $200,000 February 16, 2012 FOR VALUE RECEIVED, the undersigned, MEDYTOX DIAGNOSTICS, INC. |
|
| January 24, 2012 |
Termination of a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): January 18, 2012 Medytox Solutions, Inc. (Exact Name of Registrant as Specified in Its Charter) Nevada (State or Other Jurisdiction of Incorporation) 000-54346 54-2156042 (Commission |
